Some people might question why now, but if a company wants to get approval for a trial it needs to show it has the funds to complete it.
Column 1 1 Proceeds from the Placement will be used to:- fund further clinical development of OPT-302 as a therapy for wet Age-related Macular Degeneration (“wet AMD” or “wAMD” through commencement of two concurrent Phase 3 pivotal registrational trials in approximately 660 wet AMD patients each; and- manufacture sufficient quantities of clinical grade OPT-302 for Phase 3 clinical development
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Raises A$50 million in Institutional Placement
Ann: Opthea Raises A$50 million in Institutional Placement, page-3
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
41.0¢ |
Change
0.005(1.23%) |
Mkt cap ! $504.7M |
Open | High | Low | Value | Volume |
41.5¢ | 42.0¢ | 40.0¢ | $458.6K | 1.119M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 298731 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 49490 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 298731 | 0.410 |
9 | 198682 | 0.405 |
14 | 229947 | 0.400 |
10 | 329894 | 0.395 |
10 | 143374 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 49490 | 1 |
0.420 | 203206 | 7 |
0.425 | 41876 | 2 |
0.440 | 13031 | 2 |
0.445 | 1 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |